Share price: 121.16p

AGM Statement

8th May 2019

Cello Health plc (AIM: CLL), the global healthcare-focused advisory Group, announces that at the Annual General Meeting to be held later today Chairman Chris Jones will make the following statement:

“The Group has had a very good start to the year. For the first quarter, the Group has experienced good like-for-like net revenue and headline profit before tax growth. We are also confident regarding performance in the second quarter, and expect to report robust headline profit before tax growth for the first half of the year.

“At a segment operating level, Cello Health has had an excellent first quarter. In particular, the performances in our consulting businesses and in the US overall are notable. We expect the second quarter to continue this trend.

“Cello Signal has also made a solid start to the year in line with expectations.

“The Group’s balance sheet remains strong, with better than expected cash conversion so far in 2019, continuing the strong cash conversion performance delivered in 2018. The Group continues to assess suitable acquisitive growth opportunities in the US.

“The Board is therefore confident of achieving a successful full year result in 2019, in line with expectations.”

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150